News
Global air cargo brand Turkish Cargo chosen as the best air cargo brand of Europe
Global air cargo brand Turkish Cargo chosen as the best air cargo brand of Europe The successful brand of national flag carrier Turkish Airlines, Turkish Cargo is chosen as the best cargo brand of Europe and received “Best Cargo...
Clinical Trials
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX?CoV2373 is a stable, prefusion protein made using Novavax’ nanoparticle technology...
Clinical Trials
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19
Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and selective inhibitor of TRPC6 may alleviate the damage to the lung and decrease the...
Drug Research
aTyr Pharma Announces Research Collaboration with Medical University of South Carolina
aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....
Drug Research
Intec Pharma Announces New Research Collaboration Agreement with MSD
Intec Pharma Ltd. announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential.
"We are very excited to continue to work with...
Drug Research
Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research
Thermo Fisher Scientific announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of new pathways and tools to diagnose and better manage transplant patients.
The mission of the TIC is...
Drug Research
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
WuXi Biologics, a global company with leading open-access biologics technology platforms, and AB2 Bio Ltd., a Swiss advanced clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, announced that they have entered into a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read